Finally, evidence assembled in recent years indicate that, in addition to its well-documented capacity to govern cell cycle progression, p53 activation also has a major impact on metabolic processes, including glucose transport (58) and obesity (59). This evidence concerns the gene TP53 and obesity due to melanocortin 4 receptor deficiency.